Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hoth Therapeutics and UCRI to perform critical studies for HT-006 antibiotic

pharmaceutical-technologyMarch 19, 2021

Tag: Hoth Therapeutics , UCRI , HT-006 , WRAIR

PharmaSources Customer Service